GALANIN is a 29 amino acid peptide that was initially isolated from the porcine intestine (7) . Galanin shares only minor sequence homology with other known peptides and is expressed in both central and peripheral nervous systems (7, 15, 27) . Galanin-immunoreactive nerve fibers are distributed widely throughout the digestive tract of a number of mammalian species (16) . The peptide has been localized immunocytochemically to nerve fibers within both the endocrine and the exocrine portions of the pancreas (9) .
To date, investigation of the pancreatic effects of galanin have focused mainly on the endocrine portion of the gland, although prior studies have suggested that galanin may inhibit exocrine function in rats and dogs (1, 13, 31) . In rats and dogs, galanin inhibits the release of insulin and somatostatin and stimulates release of glucagon (10, 17) . Galanin is released from intrapancreatic nerves by mixed pancreatic nerve stimulation in concentrations that axe sufficient to inhibit insulin secretion (11) . Because of these effects, and because the peptide is localized to nerves innervating acinar tissues, we investigated the effects of galanin on exocrine pancreatic function.
The current study sought to employ in vivo and in vitro techniques to investigate potential inhibitory effects of galanin in the rat pancreas. The general goals of the investigation were to: 1) determine if galanin is an inhibitor in vivo of stimulated pancreatic exocrine function in rats 2) determine if inhibitory actions are exerted directly on the acinar cell; and 3) examine the ability ofgalanin to affect exocrine function by modulation of intrapanereatic neurotransmission. In order to achieve these goals, experiments were performed to: 1) determine if galanin inhibits stimulated amylase secretion in anesthetized rats; 2) determine if galanin affects amylase release from purified acini; and 3) determine ifgalanin decreases amylase secretion and acetylcholine release from pancreatic lobules, containing islet tissues and intrapancreatic neurons, in addition to acini.
METHOD

Supplies
Rat galanin and cholecystokinin octapeptide (CCK-8) were obtained from Peninsula Laboratories, Belmont, CA. Peptides were reconstituted in 1% (w/v) bovine serum albumin to a concentration of l0 -4 M. Aliquoted peptides were stored at -40°C until use. Collagenase, 2-deoxy glucose (2-DG), bethanechol, atropine, veratridine, tetrodotoxin, bovine serum albumin (BSA), soybean trypsin inhibitor, and aprotinin were purchased from Sigma Chemical Company, St. Louis, MO.
[3H]Methyl choline chloride was purchased from New England Nuclear, Boston, MA.
[~4C]Acetylcholine was purchased from Amersham, Arlington Heights, IL. which they were allowed water ad lib, rats were weighed and given an intraperitoneal injection of urethane, 1.25 mg/g body weight. Through a short midline laparotomy incision, the entrance of the bile pancreatic duct into the duodenum was cannulated with polyethylene tubing (PE-50, Becton-Dickinson, Parsippany, N J) for total diversion of endogenous bile pancreatic secretion. A duodenostomy tube was placed to allow reinfusion of previously harvested bile pancreatic juice. This juice was collected from other male Sprague-Dawley rats and stored at -20°C until reinfused. Intravenous access was secured via the femoral veins and normal saline was infused at a rate of 1.6 cc/h throughout the experiment. A tracheostomy was placed to insure a patent airway.
After bile pancreatic flow was demonstrated, serial collection at 10-min intervals was maintained for 120 min. The volume of secretion for each interval was measured gravimetrically. Amylase activity was measured by the method of Bernfeld (6) . All assays were performed in duplicate.
Inhibitory effects were examined by infusing galanin (40 #g/ kg/h) continuously starting before 2-DG (100 mg/kg subcutaneously), bethanechol (3 mg/kg/h intravenously), or CCK-8 (0.25 ttg/kg/h intravenously).
In Vitro Studies
Dispersed acini. After an overnight fast, rats were weighed and sacrificed. The pancreas was harvested; adherent fat and lymphatic tissue was removed. The gland was cut into 12 to 15 pieces and placed in chilled Krebs ringer HEPES buffer, pH 7.4. The buffer contained (each in mM) NaCI 103, KCI 4.8, KH2PO4 1.2, glutamine 2, glucose 5, HEPES 25, CaCI2 1.3, and MgSO4, 0.6. Also included were minimal essential media amino acids, 1% (v/v) (GIBCO BRL, Gaithersburg, MD), nonessential amino acids, 0.5% (v/v) (GIBCO), and BSA, 0.2% (w/v). The pancreatic tissues were dispersed with collagenase as previously described (4, 19, 29) . Briefly, under 100% oxygen, three 15-min collagenase (0.1 mg/ml buffer) digestions were performed at 37°C (with fresh buffer instilled between each digestion), and acini were then dispersed by trituration with pipettes of decreasing tip diameter. Acini were diluted with buffer and aliquoted into tubes containing galanin alone, or into tubes containing stimulant plus either galanin or equal volume of 1% (w/v) BSA (control). The concentration range used for galanin alone was 10 -s to 10 -13 M. Stimulant concentration ranges used were 10 -7 to 10 -3 M for bethanechol, and 10 -13 to 10 -8 M for cholecystokinin. Galanin concentration in the presence of stimulant was either 10 -8 M or 10 -6 M. After incubation at 37°C for 30 rain, the tubes were chilled and centrifuged. Amylase activity was determined in duplicate for the media and for the acini. Acini were lysed with a 0.1% Triton X-100 buffer, pH 8.0, containing 0.01 M NaH2PO4 and 0.1% BSA (w/v). Amylase release was expressed as percentage of total cellular content. Mean percent of total amylase release from duplicate incubations for each rat was used for statistical analysis.
Isolated lobules. Amylase release. A technique modified from
Scheele and Palade (24) was used for isolated lobule studies. After an overnight fast, rats were weighed and sacrificed. The pancreas was harvested and pinned to a wax plate. Using 2.0 power optical magnification, individual lobules from throughout the pancreas were identified and excised, taking special care not to damage the pancreatic tissue with instruments. Lobules were kept in an oxygenated HEPES-biearbonate buffer, pH 7.4, during harvest. Buffer contained (each in mM) NaCI 103, KC1 4.7, CaCI2 2.6, MgCI2 1.1, NaH2PO4 1.2, glucose 11, HEPES 25, NaHCO3 25, and L-glutamine 2, as well as minimal essential 2,
Effects of galanin on 2-deoxy glucose (2-DG)-stimulated exocrine pancreatic function. Galanin (40 ~/kg/h) was infused from 20-120 rain, and 2-DG (100 mg/kg) was injected subcutaneoudy at 40 min~ All values for galanin-treated animals were sit, nifaumtly different from controls from 50-120 rain for amylase release. Integrated amylase secretion was significantly decreased for rats receiving galanin infusion and 2-DG injection. For both groups, n = 6. amino acids, 2% (v/v), BSA, 1% (w/v), soybean trypsin inhibitor, 0.1% (w/v), and aprotinin 680 KIU/ml. Four lobules were added to each incubation flask. The flasks contained buffer plus atropine 10 -5 M, tetrodotoxin 10 -5 M, galanin 10 -s or 10 -6 M, or above medium alone. After a 30-min incubation at 37°C under a 95% 02/5% CO2 atmosphere, the lobules were washed. A second incubation was then performed including agonists (75 mM KC1 or veratridine 10 -4 M) in the presence or absence of the above antagonists or galanin. Two control flasks were prepared with no antagonist or agonist for each experiment. Lobules and media were separated, and lobules were mechanically homogenized in a 1% Triton X-100 buffer, pH 8.0, containing CaC12 2.5 mM, HEPES 25 raM, and KCI 0.1 M. The media and diluted homogenate were analyzed for amylase content. Mean percen*_~ge of total cellular amylase released during incubations for each rat was used for statistical analysis.
Tritiated acetylcholine release. Acetylcboline (ACh) re!e~_~ from isolated lobules was determined using [3H]ACh as a marker. The same incubation buffer was used as in other lobule studies, with the addition of physost~mine (50 ttM). Two lobules in 1 ml buffer per flask were incubated with 0.2 I~M [3H]methyl choline chloride (specific activity, 88 Ci/mmoD for 1 hour at 370C under 95%O2/5%CO2. After initial radiolabelin~ lobules were washed twice with fresh buffer containing hemicholinium (10 #M). A 30-min period for equilibration was followed by incubation in buffer (30 rain, 37°C) with veratridine (10 -4 M) or KCI (75 raM). After removal of media, lobules were solubilized with 1 ml Solvable (Du Pont) for 2 h at 55°C. Glacial acetic acid (100 ~1) was then added to the solubilized tissue, and finally 10 ml Ecolite was added for scintillation counting. Measured counts per minute was used for analysis. Released tritium was confirmed to be acetylcholine by separation on a 0.5 × 50 cm ion exchange column (Bio-Rex 70, 200-400 mesh, Bio-Rad) eluted with Na2HPO4 0.1 M at pH 7.0 (14).
Stat&tical Methods
Two-way analysis of variance was performed on all in vivo and acinar preparation results, and when significant differences (p < 0.05) were noted, individual Bonferroni t-tests were performed on analogous pairs to ascertain differences. Lobule preparation results were analyzed with paired Student's t-tests. All results are reported as mean _+ SEM.
RESULTS
In Vivo Effect of Galanin on Pancreatic Exocrine Function
Intravenous infusion of galanin (40 #g/kg/h) did not affect basal amylase output from anesthetized rats (Fig. 1) . Administration of 2-deoxy glucose (100 mg/kg subcutaneously) significantly stimulated amylase release. Increases were noted within 10 min of injection, were maximum by 40 min, and remained elevated relative to baseline throughout the entire study period. 2-Deoxy glucose-stimulated amylase secretion was significantly reduced by intravenous infusion of galanin, with inhibitory effects noted throughout the 80-min experimental period, F(1, 11) = 36.6, p < 0.001 (Fig. i) . Maximal amylase secretion was 5.8 ---0.1 times baseline for control rats, and 3.1 ___ 0.1 times baseline for galanin-treated rats, a 47% reduction relative to control. Total integrated amylase secretion was calculated for the 80-min experimental period for both galanin infusion and control groups. Integrated amylase secretion was significantly decreased in the group of rats exposed to galanin, F(1, 1) = 7.14, p < 0.02 (Fig. 1) .
Pancreatic secretory response to intravenous CCK-8 (0.25 #g/kg/h) was significantly increased throughout the experimental period (Fig. 2) . Continuous intravenous infusion ofgalanin (40 /=g/kg/min) produced significant suppression of CCK-8-stimulated exocrine secretion during the 80-rain experimental period, F(I, 11) = 12.2,p < 0.001 (Fig. 2) . Integrated amylase secretion following CCK stimulation was decreased by 41% in animals receiving galanin coinfusion, F(1, 1) = 3.45, p = 0.07.
Bethanechol infusion (3 mg/kg/h) also stimulated pancreatic amylase secretion, with significant increases noted by 10 rain and plateau values by 30 rain. Continuous intravenous infusion of galanin (40/=g/kWh) during bethanechol infusion resulted in no significant suppression of integrated amylase output, F(1, 1) = 0.51, p = 0.48 (Fig. 3) .
In Vitro Effects of Galanin on Pancreatic Exocrine Function
Dispersed acini. Galanin had no effect on basal amylase release from dispersed acini. Basal amylase release was 4.5 + 0.6% of total cellular content and incubation of acini in the presence of varying concentrations ofgalanin (10 -~3 to 10 -s M) produced no significant change ( Table 1) .
Exposure of acini to incremental concentrations of bethanechol (10 -7 to 10 -3 M) resulted in a dose-dependent increase in amylase release (Fig. 4) . Maximal release was noted at 3 × 10 -5 M bethanechol. Coincubation of bethanechol with galanin 
DISCUSSION
The results of the current study suggest that gaianin is an inhibitor of rat pancreatic exocrine secretion in vivo. When administered by continuous infusion, galanin caused sustained inhibition of pancreatic exocrine secretion stimulated by 2-DG or CCK-8. Yagci and coworkers have also recently reported that galanin inhibits CCK-8-stimulated pancreatic secretin in the anesthetized rat (31) . In the presem investigation, bethanecholstimulated amylase secretion was not affected by galanin. Inhibitory actions do not appear to be exerted directly upon the acinar cell, as galanin had no inhibitory activity in vitro upon dispersed acini. Galanin did not affect basal amylase release from dispersed acini, and amylase release in dispersed acini stimulated by bethaneehol or CCK-8 incubation was not altered by coineubation with galanin. For dispersed acini, the current results differ significantly from those of Ahren and cow-'orkers (1). These investigators have previously relx)rted that galanin inhibits amylase release when isolated rat acini were exposed to CCK-8 in concentrations similar to those used in the current study.
The current studies utilizing pancreatic lobules suggest that inhibition of pancreatic exocrine function by galanin may be The ability of galanin to affect pancreatic function indirectly via actions on intrapancreatic neurons has also been suggested for other, structurally unrelated, pancreatic neuropeptides. Pancreatic polypeptide has been reported to inhibit bethanechol-, CCK-8-, and 2-DG-stimulated exocrine pancreatic function in vivo. (5, 23) . Inhibition is believed to involve presynaptic modulation of acetylcholine release (14) . Neuropeptide Y, which shares sequence homology with pancreatic polypeptide, has also been shown to have indirect inhibitory effects on exocrine pancreatic function consistent with effects on cholinergic transmission (18) . Somatostatin has also been shown to act indirectly to modulate exocrine secretion (25) . From experiments using isolated perfused rat pancreas, Mulvihill et al. concluded that somatostatin inhibition was mediated via effects on intrapancreatic peptidergic neurons (20) .
In enteric neurons, galanin does not affect basal acetylcholine release, but the peptide does inhibit acetylcholine release stimulated by electrical current, vasoactive intestinal peptide, or substance P (32). Galanin causes neuronal membrane hyperpolarization by opening potassium channels, thereby decreasing input resistance and suppressing excitability. Galanin has also been noted to block voltage-gated calcium channels (26) . Effects are blocked by pertussis toxin (8) . Galanin has been noted to inhibit acetylcholine release from hippocampal slices (22) . Inhibitory effects of galanin have also been noted in pancreatic endocrine tissues. Galanin suppresses insulin release by inhibiting adenylate cyclase in the insulin-secreting cell line RINm5F (3). Galanin inhibition of insulin release appears to act via blockade of exocytosis secondary to effects on beta cell membrane G-proteins; inhibitory effects are blocked by pertussis toxin (21, 28) .
While the current data indicate that galanin affects exocrine function, at least in part, via inhibition of cholinergic neurons, other mechanisms of action for galanin are not excluded. The in vivo effects of galanin could be secondary to pancreatic vasoconstriction. Pancreatic galanin has been shown to be released by bilateral thoracic splanchnic nerve stimulation, and the peptide has been shown to coexist with epinephrine and norepinephrine in intrapancreatic and celiac neurons (2, 18) . Since galanin inhibits the release of somatostatin (10, 17) , and since somatostatin itself decreases with mixed pancreatic nerve stimulation, the involvement of this peptide seems unlikely (4) .
